More Articles Back to Article
China's Sinovac ups output with third production line
China's Sinovac Biotech will produce 2 billion doses of its COVID-19 vaccine with the addition of a third production line that the company said has received approval from China's National Medical Products Administration. Chinese health regulators approved the vaccine for use in February and it has also been approved in 30 other countries. FiercePharma (4/2)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!